Literature DB >> 17621256

Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis.

James L Wynn1, Philip O Scumpia, Matthew J Delano, Kerri A O'Malley, Ricardo Ungaro, Amer Abouhamze, Lyle L Moldawer.   

Abstract

Neonates have a higher prevalence of bacterial sepsis and have greater morbidity and mortality from sepsis than other infants and children. Our understanding of the inflammatory and immunological responses to sepsis is hampered by the lack of appropriate neonatal murine models. In the present report, we have developed a cecal slurry model of generalized peritonitis in neonatal mice (age range, 5-7 days) and compared the outcome and the innate and adaptive cellular responses of these animals with those of the young adult animals (age range, 7-10 weeks) with sepsis induced either by cecal slurry administration or by cecal ligation and puncture. Neonatal mice were more susceptible to sepsis and mounted a markedly attenuated systemic inflammatory response compared with young adult animals (specifically, decreased plasma interferon gamma; interleukins 1alpha and 1beta; regulated on activation, normal T expressed and secreted (RANTES); and tumor necrosis factor alpha concentrations). Compared with young adult animals, septic neonatal mice did not lose significant percentage or absolute number of splenic CD4+ T cells. These findings suggest that the cecal slurry model of generalized peritonitis can produce sepsis in neonatal mice with dose-dependent lethality. Inherent differences in the host response to polymicrobial sepsis between neonatal and young adult animals may explain the increased sensitivity of the neonatal mouse to generalized peritonitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621256     DOI: 10.1097/SHK.0b013e3180556d09

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  80 in total

1.  Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis.

Authors:  Alex G Cuenca; James L Wynn; Kindra M Kelly-Scumpia; Philip O Scumpia; Lizette Vila; Matthew J Delano; Clayton E Mathews; Shannon M Wallet; Westley H Reeves; Kevin E Behrns; Dina C Nacionales; Philip A Efron; Steven L Kunkel; Lyle L Moldawer
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury.

Authors:  Kathryn A Seely; Joseph H Holthoff; Samuel T Burns; Zhen Wang; Keshari M Thakali; Neriman Gokden; Sung W Rhee; Philip R Mayeux
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

3.  Deficiency in milk fat globule-epidermal growth factor-factor 8 exacerbates organ injury and mortality in neonatal sepsis.

Authors:  Laura W Hansen; Adam Khader; Weng-Lang Yang; Asha Jacob; Tracy Chen; Jeffrey M Nicastro; Gene F Coppa; Jose M Prince; Ping Wang
Journal:  J Pediatr Surg       Date:  2016-12-30       Impact factor: 2.545

4.  Cell-free hemoglobin augments acute kidney injury during experimental sepsis.

Authors:  Ciara M Shaver; Melinda G Paul; Nathan D Putz; Stuart R Landstreet; Jamie L Kuck; Lauren Scarfe; Nataliya Skrypnyk; Haichun Yang; Fiona E Harrison; Mark P de Caestecker; Julie A Bastarache; Lorraine B Ware
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-31

5.  Heme oxygenase-1 deficiency promotes severity of sepsis in a non-surgical preterm mouse model.

Authors:  Kazumichi Fujioka; Flora Kalish; Hui Zhao; Ronald J Wong; David K Stevenson
Journal:  Pediatr Res       Date:  2018-05-23       Impact factor: 3.756

6.  Xiphoid Surface Temperature Predicts Mortality in a Murine Model of Septic Shock.

Authors:  Orlando Laitano; David Van Steenbergen; Alex J Mattingly; Christian K Garcia; Gerard P Robinson; Kevin O Murray; Thomas L Clanton; Elizabeth A Nunamaker
Journal:  Shock       Date:  2018-08       Impact factor: 3.454

7.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

8.  C23, an oligopeptide derived from cold-inducible RNA-binding protein, suppresses inflammation and reduces lung injury in neonatal sepsis.

Authors:  Naomi-Liza Denning; Weng-Lang Yang; Laura Hansen; Jose Prince; Ping Wang
Journal:  J Pediatr Surg       Date:  2019-01-04       Impact factor: 2.545

9.  Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.

Authors:  Sarah J Atkinson; Meghan Nolan; Lindsey Klingbeil; Kelli Harmon; Patrick Lahni; Basilia Zingarelli; Hector R Wong
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

10.  Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection.

Authors:  Charalambos Gogos; Antigone Kotsaki; Aimilia Pelekanou; George Giannikopoulos; Ilia Vaki; Panagiota Maravitsa; Stephanos Adamis; Zoi Alexiou; George Andrianopoulos; Anastasia Antonopoulou; Sofia Athanassia; Fotini Baziaka; Aikaterini Charalambous; Sofia Christodoulou; Ioanna Dimopoulou; Ioannis Floros; Efthymia Giannitsioti; Panagiotis Gkanas; Aikaterini Ioakeimidou; Kyriaki Kanellakopoulou; Niki Karabela; Vassiliki Karagianni; Ioannis Katsarolis; Georgia Kontopithari; Petros Kopterides; Ioannis Koutelidakis; Pantelis Koutoukas; Hariklia Kranidioti; Michalis Lignos; Konstantinos Louis; Korina Lymberopoulou; Efstratios Mainas; Androniki Marioli; Charalambos Massouras; Irini Mavrou; Margarita Mpalla; Martha Michalia; Heleni Mylona; Vassilios Mytas; Ilias Papanikolaou; Konstantinos Papanikolaou; Maria Patrani; Ioannis Perdios; Diamantis Plachouras; Aikaterini Pistiki; Konstantinos Protopapas; Kalliopi Rigaki; Vissaria Sakka; Monika Sartzi; Vassilios Skouras; Maria Souli; Aikaterini Spyridaki; Ioannis Strouvalis; Thomas Tsaganos; George Zografos; Konstantinos Mandragos; Phylis Klouva-Molyvdas; Nina Maggina; Helen Giamarellou; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2010-05-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.